Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection

Journal of Immunological Methods

Volumn 370, Issue 1-2, 2011, Pages 55-64

  Borgström, Emilie ^a   Andersen, Peter ^b   Andersson, Lena ^c   Julander, Inger ^a   Källenius, Gunilla ^d   Maeurer, Markus ^e   Norrby, Maria ^a   Rosenkrands, Ida ^b   Tecleab, Teghesti ^c   Bruchfeld, Judith ^a   Gaines, Hans ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CFP 10; Diagnostic methods; Esat 6; Fascia; Tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; CYTOKINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON;

ADULT; AGED; ARTICLE; BLOOD; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TUBERCULOSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; T LYMPHOBLAST; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79960038090     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.05.008     Document Type: Article

References (40)

1. Aagaard C., Hoang T.T., et al. Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS One 2009, 4(6):e5930.
2. Andersen P., Munk M.E., et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356(9235):1099-1104.
3. Arend S.M., de Haas P., et al. ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii. J. Infect. Dis. 2005, 191(8):1301-1310.
4. Bergstedt W., Tingskov P.N., et al. First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent. PLoS One 2010, 5(6):e11277.
5. Billeskov R., Vingsbo-Lundberg C., et al. Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J. Immunol. 2007, 179(6):3973-3981.
6. Black G.F., Dockrell H.M., et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J. Infect. Dis. 2001, 184(3):322-329.
7. Brock I., Munk M.E., et al. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int. J. Tuberc. Lung Dis. 2001, 5(5):462-467.
8. Butera O., Chiacchio T., et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect. Dis. 2009, 9:182.
9. Chapman A.L., Munkanta M., et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002, 16(17):2285-2293.
10. Corbett E.L., Watt C.J., et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 2003, 163(9):1009-1021.
11. Diel R., Loddenkemper R., et al. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010, 137(4):952-968.
12. Dinser R., Fousse M., et al. Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) 2008, 47(2):212-218.
13. Farhat M., Greenaway C., et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int. J. Tuberc. Lung Dis. 2006, 10(11):1192-1204.
14. Gaines H., Biberfeld G. Measurement of lymphoproliferation at the single-cell level by flow cytometry. Methods Mol. Biol. 2000, 134:243-255.
15. Gaines H., Andersson L., et al. A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry. J. Immunol. Methods 1996, 195(1-2):63-72.
16. Goletti D., Butera O., et al. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J. Infect. Dis. 2006, 194(7):984-992.
17. Goletti D., Butera O., et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur. Respir. J. 2010, 36(1):135-142.
18. Huebner R.E., Schein M.F., et al. The tuberculin skin test. Clin. Infect. Dis. 1993, 17(6):968-975.
19. Kabeer B.S., Sikhamani R., et al. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 2010, 24(2):323-325.
20. Lagrelius M., Jones P., et al. Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 2006, 33(3):156-165.
21. Lalvani A., Pathan A.A., et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001, 357(9273):2017-2021.
22. Lalvani A., Pathan A.A., et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am. J. Respir. Crit. Care Med. 2001, 163(4):824-828.
23. Lange C., Mori T. Advances in the diagnosis of tuberculosis. Respirology 2010, 15(2):220-240.
24. Lange C., Pai M., et al. Interferon-gamma release assays for the diagnosis of activetuberculosis: sensible or silly?. Eur. Respir. J. 2009, 33(6):1250-1253.
25. Leyten E.M., Arend S.M., et al. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin. Vaccine Immunol. 2007, 14(7):880-885.
26. Mack U., Migliori G.B., et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J. 2009, 33(5):956-973.
27. Mazurek G.H., Jereb J., et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 2005, 54(RR-15):49-55.
28. Menzies D., Pai M., et al. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 2007, 146(5):340-354.
29. Menzies D., Gardiner G., et al. Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. Int. J. Tuberc. Lung Dis. 2008, 12(5):498-505.
30. Pai M. Spectrum of latent tuberculosis-existing tests cannot resolve the underlying phenotypes. Nat. Rev. Microbiol. 2010, 8(3):242. author reply 242.
31. Pai M., Zwerling A., et al. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 2008, 149(3):177-184.
32. Pai M., Minion J., et al. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr. Opin. Pulm Med. 2010, 16(3):271-284.
33. Ravn P., Demissie A., et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 1999, 179(3):637-645.
34. Richeldi L. An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 2006, 174(7):736-742.
35. Rieder H.L., Watson J.M., et al. Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Eur. Respir. J. 1996, 9(5):1097-1104.
36. Sester M., Sester U., et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int. 2004, 65(5):1826-1834.
37. Sester U., Junker H., et al. Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. Nephrol. Dial. Transplant. 2006, 21(11):3258-3268.
38. Svahn A., Linde A., et al. Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J. Immunol. Methods 2003, 277(1-2):17-25.
39. Tena-Coki N.G., Scriba T.J., et al. CD4 and CD8 T-cell responses to mycobacterial antigens in African children. Am. J. Respir. Crit. Care Med. 2010, 182(1):120-129.
40. Tully G., Kortsik C., et al. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J. Immunol. 2005, 174(4):2174-2184.